Scientific article
Open access

Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention

Published inMolecular pharmaceutics, vol. 10, no. 10, p. 3564-3573
Publication date2013

5P12-RANTES is a recently developed chemokine analogue that has shown high level protection from SHIV infection in macaques. However, the feasibility of using 5P12-RANTES as a long-term HIV prevention agent has not been explored partially due to the lack of available delivery devices that can easily be modified for long-term release profiles. Glycosaminoglycans (GAGs) have been known for their affinity for various cytokines and chemokines, including native RANTES, or CCL5. In this work, we investigated used of GAGs in generating a chemokine drug delivery device. Initial studies used surface plasmon resonance analysis to characterize and compare the affinities of different GAGs to 5P12-RANTES. These different GAGs were then incorporated into drug delivery polymeric hydrogels to engineer sustained release of the chemokines. In vitro release studies of 5P12-RANTES from the resulting polymers were performed, and we found that 5P12-RANTES release from these polymers can be controlled by the amount and type of GAG incorporated. Polymer disks containing GAGs with stronger affinity to 5P12-RANTES resulted in more sustained and longer term release than did polymer disks containing GAGs with weaker 5P12-RANTES affinity. Similar trends were observed by varying the amount of GAGs incorporated into the delivery system. 5P12-RANTES released from these polymers demonstrated good levels of CCR5 blocking, retaining activity even after 30 days of incubation.

  • Chemokines/chemistry
  • Chemokines, CC/administration & dosage/chemistry
  • Drug Carriers/chemistry
  • Glycosaminoglycans/chemistry
  • HIV Infections/prevention & control
  • Humans
  • Polymers/chemistry
  • Surface Plasmon Resonance
Research group
Citation (ISO format)
WANG, Nick X et al. Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention. In: Molecular pharmaceutics, 2013, vol. 10, n° 10, p. 3564–3573. doi: 10.1021/mp3007242
Main files (1)
Article (Published version)
ISSN of the journal1543-8384

Technical informations

Creation12/10/2014 11:19:00 AM
First validation12/10/2014 11:19:00 AM
Update time03/14/2023 10:25:07 PM
Status update03/14/2023 10:25:06 PM
Last indexation01/16/2024 3:05:52 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack